Coverage, coding, and billing requirements for BAVENCIO® (avelumab) Injection 20mg/mL may vary by payer, plan, setting of care, and patient.
Please download billing and coding resources for BAVENCIO by clicking below:
Please call CoverOne if you have specific reimbursement questions about a patient, or fax a completed CoverOne Enrollment Form to 1-800-214-7295 or enroll online to request patient-specific services.
©2024 Merck KGaA, Darmstadt, Germany or its affiliates. All rights reserved. EMD Serono is the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada. BAVENCIO, TEPMETKO and CoverOne are registered trademarks of Merck KGaA, Darmstadt, Germany or its affiliates.
US-MULO-00096 06/24
©2024 Merck KGaA, Darmstadt, Germany or its affiliates. All rights reserved. EMD Serono is the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada. BAVENCIO, TEPMETKO and CoverOne are registered trademarks of Merck KGaA, Darmstadt, Germany or its affiliates.
US-MULO-00096 06/24
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch, or call 1-800-FDA-1088. The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient. The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.
